NewsStocksTamil Nadu's Sresan Pharma Under Scrutiny: Cough Syrup Found Contaminated with Toxic ChemicalTamil Nadu's Sresan Pharma Under Scrutiny: Cough Syrup Found Contaminated with Toxic Chemical
The Union Health Ministry has confirmed that samples of Coldrif Cough Syrup, manufactured by Tamil Nadu-based Sresan Pharma, contain diethylene glycol (DEG) beyond permissible limits. Initial tests by CDSCO and MPFDA showed no contamination, but subsequent testing by Tamil Nadu FDA at the manufacturer's premises in Kanchipuram revealed DEG contamination. The government has launched a Risk-Based Inspection drive targeting 19 drug samples across six states. A multidisciplinary team is investigating recent deaths in Chhindwara, Madhya Pradesh, though no direct link has been established yet.
*this image is generated using AI for illustrative purposes only.
In a concerning development for the pharmaceutical industry and public health, the Union Health Ministry has confirmed that samples of Coldrif Cough Syrup, manufactured by Tamil Nadu-based Sresan Pharma, contain diethylene glycol (DEG) beyond permissible limits. This revelation comes after a series of tests and inspections, highlighting the critical importance of stringent quality control in drug manufacturing.
Initial Testing and Subsequent Findings
The investigation into Sresan Pharma's product underwent multiple phases:
| Testing Authority | Samples Tested | Initial Result |
|---|---|---|
| CDSCO | 6 | No contamination |
| MPFDA | 3 | No contamination |
| Tamil Nadu FDA | Unspecified | DEG contamination detected |
The Tamil Nadu Food and Drug Administration (FDA) conducted tests at the manufacturer's premises in Kanchipuram, which ultimately revealed the presence of DEG contamination, contradicting earlier findings.
Government Response
In light of these findings, the government has taken swift action:
- Launched a Risk-Based Inspection drive
- Targeted 19 drug samples across six states
- Aim to identify quality control gaps in manufacturing sites
Ongoing Investigation
A multidisciplinary team is currently analyzing medical and environmental samples to determine the cause of recent deaths in Chhindwara, Madhya Pradesh. While a direct link has not been established, the timing of this investigation coincides with the discovery of contaminated cough syrup.
Implications and Concerns
This incident raises serious questions about:
- The efficacy of current quality control measures in pharmaceutical manufacturing
- The potential health risks associated with contaminated over-the-counter medications
- The need for more rigorous and frequent testing of pharmaceutical products
The presence of diethylene glycol, a toxic substance, in cough syrup is particularly alarming given its potential for severe health consequences. This situation underscores the critical importance of maintaining stringent safety standards in the pharmaceutical industry to protect public health.
As the investigation continues, it remains to be seen what further actions will be taken against Sresan Pharma and whether this incident will lead to broader reforms in pharmaceutical quality control and testing procedures across India.
15
